 SALT LAKE CITY , Oct. 27, 2022 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2022 results on Thursday, November 10, 2022, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. 